Med spas are one of the hottest categories in small business acquisitions, and for good reason. The medical aesthetics market is growing rapidly, margins are exceptional (often 55 to 65 percent EBITDA), treatments create naturally recurring revenue, and demand has proven surprisingly resilient through economic downturns. The "lipstick effect," a phenomenon observed during recessions where consumers continue spending on appearance-related services even while cutting other discretionary expenses, appears to extend well beyond lipstick and into injectables and laser treatments.
But the surface-level appeal masks several structural risks that are specific to this industry and largely invisible to first-time buyers who have not operated in the space. Our analysis of med spa listings across multiple markets identified recurring patterns that separate the deals experienced acquirers pursue from the ones they walk away from.
Practitioner Portability Is the #1 Risk
In most businesses, customer concentration is the primary revenue risk. In med spas, the risk sits one layer deeper: practitioner concentration. The injectors, aestheticians, and laser technicians who perform treatments are the business's primary relationship with the client. When a skilled injector leaves, they take their clients with them.
The dynamics here are similar to hairdressers and financial advisors. Clients develop trust with the person performing an intimate service (someone is literally pointing a needle at their face), and that trust is not easily transferred to a new provider. Industry experience suggests that a departing injector can take 50 percent or more of their client book when they leave.
This makes practitioner turnover the single most important due diligence item in a med spa acquisition. You need to understand how many practitioners the business employs, how long each has been with the business, what percentage of revenue each practitioner generates, and how their compensation compares to market rates.
The most effective mitigation is simple, even if it feels counterintuitive to cost-conscious buyers: pay above market. The margin structure of med spas is generous enough that moving from 60 percent to 55 percent net margins by paying practitioners well above the going rate is an extremely good trade. You are buying stability and reducing the operational burden of constant recruiting, hiring, and training.
The MSO Structure Can Kill Your Financing
If the med spa performs any medical procedure that requires physician oversight (Botox, dermal fillers, certain laser treatments), a non-physician buyer cannot simply purchase and operate the business. Medical regulations in most states require that a licensed physician provide oversight for medical procedures, even when those procedures are performed by nurse practitioners or trained technicians.
The standard workaround is a Management Services Organization (MSO) structure, where the buyer's company provides management, staffing, marketing, and administrative services to a separate professional corporation (PC) owned by a physician. The PC holds the medical licenses and employs the medical director. The MSO contracts with the PC to manage everything else and receives the majority of revenue through the management fee.
This works, but it creates two significant complications for buyers.
First, most SBA lenders are unfamiliar with MSO structures and will struggle to underwrite the deal. Only a handful of lenders have experience with MSO-based med spa acquisitions. Many banks will request that the medical director personally guarantee the SBA loan, which is typically a non-starter (why would a physician guarantee a loan for a business they do not own?). Identifying an MSO-experienced lender early in the process is critical.
Second, the medical director relationship must be negotiated upfront and built into the financial model. The medical director receives ongoing compensation (either a salary or a percentage of revenue), and their willingness to continue post-acquisition is not guaranteed. If the current medical director leaves and you cannot find a replacement, you cannot legally offer the services that generate most of the revenue.
Real Estate Can Break the Economics
Med spas need to be in good locations with affluent foot traffic, which means expensive commercial leases. And unlike a restaurant or retail store, a med spa requires significant tenant improvements: treatment rooms with proper plumbing and ventilation, specialized electrical for laser equipment, and build-outs that meet health department and potentially state medical board requirements.
This creates a fixed cost structure that is almost entirely inflexible. Rent, buildout amortization, base practitioner pay, insurance, and lease obligations do not change whether you see 50 patients a week or 150. A 10 percent decline in revenue can produce a 30 to 40 percent decline in cash flow because there is so little variable cost to cut.
When real estate is bundled with the business, the math can fall apart entirely. A med spa generating $270,000 in cash flow that includes $3 million in real estate cannot service both business acquisition debt and a commercial mortgage simultaneously. The annual mortgage service alone on $3 million in commercial real estate would consume the majority of the cash flow. In cases like this, the business and the real estate must be evaluated as separate investments, and if the combined economics do not work, the deal structure needs to change (sale-leaseback, separate real estate financing, or a reduction in the combined price).
Revenue Recurrence Is Real but Varies by Service
Med spa revenue is frequently described as "recurring," but the quality of that recurrence varies significantly by service type.
Injectable treatments (Botox, fillers) are the most durable revenue stream. Patients return on predictable cycles, typically every 90 to 120 days for Botox and 9 to 12 months for fillers. The trust and switching costs are high. This is the revenue stream that most closely resembles a subscription.
Laser treatments (hair removal, skin resurfacing) are purchased in packages, typically 4 to 8 sessions. Revenue during the package is predictable, but renewal rates vary. The good news is that patients who have established trust with a provider are unlikely to switch for a modest discount.
Membership programs, where clients pay a monthly fee for a certain number of treatments or discounts, provide predictable monthly revenue but can carry meaningful churn. Members who exhaust their initial enthusiasm or face budget pressure will cancel, and the cancellation is painless (no community pull, no social pressure to stay, unlike a gym).
When evaluating a med spa, decompose revenue by service type and assess the durability of each stream independently. A med spa that generates 70 percent of revenue from injectables has a more defensible revenue base than one that generates 70 percent from one-time aesthetic treatments.
Franchise vs. Independent
Both franchise and independent med spas appear on the market regularly. Each carries distinct considerations.
Independent med spas offer full operational flexibility but require the buyer to build or inherit all systems, branding, vendor relationships, and marketing from scratch. The moat, if any, is built on location, practitioner relationships, and local reputation.
Franchise med spas provide a brand, systems, training, and marketing infrastructure but come with royalty payments (typically 5 to 7 percent of revenue), marketing fund contributions, and operational restrictions that compress margins. When a franchisor is selling its own corporate-owned locations, that should prompt serious scrutiny. The franchisor knows the business model better than anyone. If they are exiting locations, the question is why.
A general caution: the med spa franchise space has not yet produced a dominant national brand the way fitness franchising has. As of late 2024, only about 3 percent of med spas were private equity owned, and the industry remains highly fragmented. For buyers, fragmentation is a positive signal: it means there is less institutional competition bidding up prices and more room for well-run independents to thrive.
Valuation Benchmarks
Independent med spas with strong injectable revenue, stable practitioners, and clean financials typically trade at 3x to 5x SDE. Franchise med spas may command slightly higher multiples (4x to 6x EBITDA) if the brand carries equity, but the buyer must account for royalty payments reducing free cash flow.
The factors that push multiples toward the upper end: a high percentage of injectable revenue, strong practitioner retention with above-market compensation, multiple locations (proving the model scales), a medical director under a long-term contract, and a location in an affluent market with favorable lease terms.
The factors that depress multiples: owner is the primary injector (owner dependence plus practitioner risk combined), high practitioner turnover, heavy reliance on non-medical treatments, expensive real estate bundled with the business, and unresolved MSO or licensing issues.
References and Sources
- American Med Spa Association (AmSpa), industry data on med spa market size, regulatory landscape, and growth trends
- U.S. Bureau of Labor Statistics, occupational data on aesthetic practitioner compensation
- SBA Standard Operating Procedures, guidance on eligibility and structuring for medical service businesses
- Kiplinger, "The Lipstick Effect", consumer spending during economic downturns
- DealScorer analysis of med spa listings across multiple markets and deal discussions